Aarti Drugs (AARTIDRUGS) Share Price Rises 12.25% Today: Price Action and Fundamental Analysis

Aarti Drugs Share Price is Rs 452.8 as of 28 October 2026 at 9:53:01 AM IST, a gain of Rs 49.4 or 12.25% over the previous close of Rs 403.4. The stock carries a market capitalisation of Rs 3,465.52 crore, which places this Aarti Drugs stock news among the sharper moves in the Indian stock market today.

Univest data confirms the move itself, though no company-specific trigger has been identified. What the latest Univest figures do show is a stock that opened at Rs 404.75, touched a high of Rs 452.85 and is trading just below that high. The Aarti Drugs Share Price Today story is therefore one of price action first, with fundamentals and sector positioning offering the context.

Aarti Drugs Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 452.8
Previous Close	Rs 403.4
Today's Move	Rs 49.4 (+12.25%)
Open	Rs 404.75
High	Rs 452.85
Low	Rs 402
Market Capitalisation	Rs 3,465.52 crore
Market Cap Category	Small Cap

Aarti Drugs Ltd. (AARTIDRUGS) rose to Rs 452.8 from the previous close of Rs 403.4, a move of Rs 49.4 or 12.25%. The stock opened at Rs 404.75, reached a high of Rs 452.85, recorded a low of Rs 402.

Aarti Drugs Share Price Today stands at Rs 452.8, up Rs 49.4 or 12.25% from the previous close of Rs 403.4. The stock opened at Rs 404.75, touched a low of Rs 402 and a high of Rs 452.85. The price sits Rs 0.05 under the day high.

Looking at the numbers in order, the previous close of Rs 403.4 set the starting point. Aarti Drugs then opened at Rs 404.75, which was above that level, and dipped to a day low of Rs 402, a little under the previous close. From there the stock moved up to Rs 452.85, a spread of Rs 50.85 between the day low and the day high.

Measured against the open, the current price of Rs 452.8 is Rs 48.05 higher. Measured against the previous close, the gain is the 12.25% already noted. This Aarti Drugs share price rise is an intraday reading as of 9:53 AM IST, so the figures can change as trading continues. Aarti Drugs has a market capitalisation of Rs 3,465.52 crore on the latest Univest figures.

The Aarti Drugs Share Price Update above is limited to price action. The next section turns to the fundamental ratios, because a double-digit rise is easier to read when earnings, book value and returns are placed beside it.

Aarti Drugs Ltd. (AARTIDRUGS) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 3,465.52 crore
P/E Ratio	19.26x
P/B Ratio	2.3x
ROE	13.36%
ROCE	12.04%
EPS	Rs 20.95
Book Value Per Share	Rs 175.19
Dividend Yield	0.5%

Aarti Drugs Ltd. (AARTIDRUGS) fundamental metrics show P/E 19.26x, P/B 2.3x, ROE 13.36%, ROCE 12.04%. Read together, these ratios describe the company's position rather than a recommendation.

Aarti Drugs Ltd. has a market capitalisation of Rs 3,465.52 crore and falls in the Small Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 19.26x, P/B at 2.3x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 13.36% and ROCE of 12.04%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 20.95, book value per share of Rs 175.19, dividend yield of 0.5%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 30.74x, median ROE of 11.23%, median ROCE of 13.17%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	19.26x
Benchmark Median P/E	30.74x
Benchmark Average P/E	43.3x
Benchmark P/E Range	3.21x to 577.05x
Company P/B Ratio	2.3x
Benchmark Median P/B	2.71x
Company ROE	13.36%
Benchmark Median ROE	11.23%
Company ROCE	12.04%
Benchmark Median ROCE	13.17%
Company Market Capitalisation	Rs 3,465.52 crore
Benchmark Median Market Cap	Rs 696.43 crore

Aarti Drugs Ltd. (AARTIDRUGS) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Aarti Drugs Ltd. (AARTIDRUGS) has a P/E ratio of 19.26x, which is below the benchmark median of 30.74x, a difference of -37.35%. The P/E comparison frames valuation; it is not a signal to buy or sell.

Aarti Drugs Ltd. (AARTIDRUGS) has a ROE of 13.36%, which is above the benchmark median of 11.23%, a difference of +18.97%. Aarti Drugs Ltd. (AARTIDRUGS) has a ROCE of 12.04%, which is below the benchmark median of 13.17%, a difference of -8.58%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,18,204.09	34.91	4.88	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,40,780	86.02	14.25	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,73,828.11	82.48	9.53	26.76	19.27
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,15,520.92	25.79	4.32	19.69	21.39
Laurus Labs Ltd.	LAURUSLABS	1,11,304.32	105.74	20.5	18.31	18.2

Aarti Drugs Ltd. (AARTIDRUGS) has a P/E ratio of 19.26x compared with the displayed peer median of 82.48x. Peer multiples give relative context only, not a buy or sell view. Its ROE of 13.36% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 12.04% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Aarti Drugs Ltd. (AARTIDRUGS) has a market capitalisation of Rs 3,465.52 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Aarti Drugs

• Price action: the stock is at Rs 452.8, up 12.25% from the previous close of Rs 403.4, after touching Rs 452.85 during the session.
• Valuation: a P/E ratio of 19.26 and a P/B ratio of 2.3 are below the same-industry medians of 30.74 and 2.71.
• Earnings and book value: EPS of Rs 20.95 and book value per share of Rs 175.19 give the valuation ratios their base.
• Returns: ROE of 13.36% is above the benchmark median of 11.23%, while ROCE of 12.04% is below the median of 13.17%.
• Sector position: market capitalisation of Rs 3,465.52 crore is above the benchmark median of Rs 696.43 crore.

About Aarti Drugs

Aarti Drugs Ltd. is a listed company in the Healthcare sector, classified under the Pharmaceuticals & Drugs industry. It is part of a benchmark group of 199 companies in the same industry, which includes large names such as Sun Pharmaceutical Industries and Divi's Laboratories as well as many smaller firms.

With a market capitalisation of Rs 3,465.52 crore, Aarti Drugs is placed above the industry median of Rs 696.43 crore. The company is listed on the NSE under the symbol AARTIDRUGS, and its Aarti Drugs NSE and Aarti Drugs BSE quotes can be followed on exchange-linked market platforms.

Frequently Asked Questions

What is the Aarti Drugs Share Price today?

Ans. Aarti Drugs Share Price is Rs 452.8 as of 9:53 AM IST on 28 October 2026. That is a gain of Rs 49.4 or 12.25% over the previous close of Rs 403.4, with a day high of Rs 452.85.

Why is Aarti Drugs share price rising today?

Ans. Univest data confirms the move itself, though no company-specific trigger has been identified. The stock rose 12.25% from the previous close of Rs 403.4 and is trading at Rs 452.8 after opening at Rs 404.75.

What is the market cap of Aarti Drugs?

Ans. Aarti Drugs has a market capitalisation of Rs 3,465.52 crore on the latest Univest figures. This is above the same-industry benchmark median of Rs 696.43 crore, which covers 199 companies in the Pharmaceuticals & Drugs industry.

What is the P/E ratio of Aarti Drugs?

Ans. The P/E ratio of Aarti Drugs is 19.26, compared with a same-industry median of 30.74 and an average of 43.3. EPS is Rs 20.95, which shows the earnings attributable to each share of the company.

What is the P/B ratio and book value of Aarti Drugs?

Ans. The P/B ratio is 2.3 against a benchmark median of 2.71. Book value per share is Rs 175.19, which is lower than the current share price of Rs 452.8, according to the latest Univest figures.

What are the ROE and ROCE of Aarti Drugs?

Ans. ROE is 13.36% and ROCE is 12.04%. ROE sits above the same-industry median of 11.23%, while ROCE sits below the median of 13.17%. ROE measures return on shareholder equity, while ROCE measures returns on capital employed.

Does Aarti Drugs pay a dividend?

Ans. The dividend yield of Aarti Drugs is 0.5% on the latest Univest figures. Dividend yield describes the current payout relative to the share price and is not a guarantee about any future dividend from the company.

How does Aarti Drugs compare with its peers?

Ans. Aarti Drugs has the lowest P/E ratio of 19.26 and the lowest P/B ratio of 2.3 among five listed peers including Sun Pharmaceutical Industries, Divi's Laboratories and Zydus Lifesciences, all with higher market capitalisation.

Track Aarti Drugs Share Price on Univest

Use Aarti Drugs Ltd. (AARTIDRUGS) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Univest lets users track the live Aarti Drugs Share Price, key fundamental ratios, 52-week levels and market insights for Aarti Drugs in one place. The Univest stock page brings the latest price, P/E ratio, P/B ratio, ROE and ROCE together, so the numbers discussed above can be followed as they update. Market Update pages on Univest also list other stocks rising today.